s+b Trend Watch: Big Pharma’s Potential in Emerging Markets
Emerging economies are becoming the industry's best hope for growth.
Pharmaceutical markets in developed countries may still be quite sizable, but in 2011–12 they were mostly stagnant—or worse. Not so in emerging economies, which are becoming the industry’s best hope for growth.
Recommended stories
The business model that drove the major drugmakers’ success isn’t working anymore. The survivors will be those that make smart strategic bets supported by winning capabilities.
Drug companies believe they’ll reap billions taking prescription medicines “over the counter.” But the strategy is no substitute for real innovation.
